Lucid Diagnostics
LUCD
86 hedge funds and large institutions have $35.5M invested in Lucid Diagnostics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 11 closing their positions.
182% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 11
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
62% more capital invested
Capital invested by funds: $21.9M → $35.5M (+$13.6M)
19% more funds holding
Funds holding: 72 → 86 (+14)
8.11% more ownership
Funds ownership: 17.52% → 25.63% (+8.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSC
Two Seas Capital
Rye,
New York
|
+$3.28M |
| 2 |
AIC
AWM Investment Company
New York
|
+$3.27M |
| 3 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$3.23M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$2.73M |
| 5 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$403K |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$167K |
| 3 |
GAM
Gotham Asset Management
New York
|
-$136K |
| 4 |
Squarepoint
New York
|
-$104K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$97.1K |
LUCD Hedge Fund Activity: Q3 2025 in Review
86 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q3 2025, worth a combined $35.5M — up 62% from $21.9M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new LUCD positions and 11 closed out — a net gain of 14 holders — while 31 added to existing stakes and 11 trimmed.
The largest buyer was Two Seas Capital, opening a new position worth an estimated $3.28M. The largest seller was Morgan Stanley, cutting an estimated $403K.
- 86 institutional investors held Lucid Diagnostics (LUCD) as of Q3 2025, up from 72 in Q2 2025.
- Funds reported $35.5M of Lucid Diagnostics stock for Q3 2025, up 62% quarter-over-quarter.
- 25 funds opened new Lucid Diagnostics positions in Q3 2025 and 11 closed out, a net change of +14 holders.
- The largest Lucid Diagnostics buyer in Q3 2025 was Two Seas Capital, an estimated $3.28M added.
- The largest Lucid Diagnostics seller in Q3 2025 was Morgan Stanley, an estimated $403K sold.
Based on aggregated 13F filings for Q3 2025.